China Approves Use of Tocilizumab for Coronavirus Patients

New Insights into the Management of Giant Cell Arteritis

Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis

Biological DMARDs in Elderly RA Patients: Use, Maintenance & Discontinuation

Recent Trials Investigated Targeted Therapies for Systemic Sclerosis
RA Effectiveness Differs Among Non-TNF Inhibitors

Upadacitinib Monotherapy Proves Promising; Plus FDA Approves Tocilizumab Autoinjector

Case Report: The Hairdresser Who Couldn’t Comb Hair

FDA Approves Subcutaneous Tocilizumab for Ages 2–17
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 7
- Next Page »